Related by context. All words. (Click for frequent words.) 69 Dasatinib 68 cediranib 68 PLX# 67 angiogenesis inhibitor 67 Mipomersen 66 proteasome inhibitor 66 mTOR inhibitor 66 ImClone Erbitux 65 BAY #-# 65 Bortezomib 65 anti angiogenic agent 65 BRAF inhibitor 64 vascular disrupting agent 64 Nexavar sorafenib 64 axitinib 64 Gleevec imatinib mesylate 64 signal transduction inhibitor 64 Panzem 64 Pertuzumab 64 Aliskiren 64 Carfilzomib 64 JAK inhibitor 64 mertansine 64 Aflibercept 63 PTK ZK 63 Tocosol Paclitaxel 63 Ixabepilone 63 HuMax CD# 63 cetuximab Erbitux 63 tafamidis 63 Deforolimus 63 histone deacetylase HDAC inhibitor 63 volociximab 63 Romiplostim 63 Xinlay 63 olaparib 63 Mirapexin 63 Zybrestat 63 gefitinib Iressa 63 Ambrisentan 63 PARP inhibitor 63 Exemestane 62 BNC# 62 fosbretabulin 62 Everolimus 62 tasocitinib 62 receptor tyrosine kinase inhibitor 62 Aplidin 62 sorafenib Nexavar 62 Erbitux cetuximab 62 Degarelix 62 generation purine nucleoside 62 rituximab Rituxan 62 canagliflozin 62 Olaparib 62 lapatinib Tykerb 62 Boceprevir 62 tyrosine kinase inhibitor 62 Treanda 62 HuMax CD4 62 pan HDAC inhibitor 62 ZD# [001] 62 multitargeted 62 targeting CD# 62 Tyrima 62 VEGF inhibitors 62 Ceflatonin 62 AEGR 62 vemurafenib 62 antiplatelet agent 62 Fampridine 62 gamma secretase inhibitor 62 bortezomib Velcade 62 YONDELIS 62 vascular disrupting agents 62 Neuvenge 62 gastrointestinal stromal tumors GIST 62 PF # [002] 61 ON #.Na 61 Guanilib 61 ranibizumab Lucentis 61 Valsartan 61 cetuximab Erbitux R 61 LBH# 61 MEK inhibitor 61 liposomal formulation 61 alefacept 61 DFMO 61 Gleevec resistant 61 Lacosamide 61 protein kinase inhibitor 61 LAF# 61 regorafenib 61 metaglidasen 61 Rotigotine 61 Anacetrapib 61 ixabepilone 61 Zactima 61 Phase Ib clinical 61 Trandolapril 61 nilotinib Tasigna 61 Pemetrexed 61 mapatumumab 61 LY# [002] 61 anti CD3 antibody 61 GW# [003] 61 evaluating tivozanib 61 Safinamide 61 Cannabinor 61 bortezomib Velcade ® 61 mecamylamine 61 Xanafide 61 erlotinib Tarceva 61 eltrombopag 61 anticancer compound 61 Sorafenib 61 XmAb# 61 zoledronic acid Zometa 61 PTK# 61 Glufosfamide 61 Zolinza 61 Avastin bevacizumab 61 Onconase 61 Eltrombopag 61 ToGA 61 Crizotinib 61 sunitinib Sutent 61 Epirubicin 61 thalidomide Thalomid 61 Daclizumab 61 enzastaurin 61 Alzhemed 61 Celgene Revlimid 61 pomalidomide 61 Hycamtin 61 Omnitarg 61 OHR/AVR# 61 metastatic malignant 60 beta interferons 60 telcagepant 60 vorinostat 60 orally dosed 60 Bapineuzumab 60 Temsirolimus 60 pemetrexed Alimta 60 multi kinase inhibitor 60 midstage trials 60 cannabinor 60 VA# [002] 60 Annamycin 60 intranasal formulation 60 ENMD # 60 MyVax 60 Sapacitabine 60 HDAC Inhibitor 60 pertuzumab 60 tarenflurbil 60 phase IIa clinical 60 Genentech Rituxan 60 neuroprotectant 60 selective agonist 60 Tasimelteon 60 elotuzumab 60 radiation sensitizer 60 Orally administered 60 FOLFOX6 60 Traficet EN 60 Cyclosporin 60 Denufosol 60 EGFR inhibitors 60 AACR NCI EORTC 60 Fluconazole 60 Amrubicin 60 midstage clinical 60 donepezil Aricept 60 Targretin 60 apremilast 60 Orencia abatacept 60 IL# PE#QQR 60 Galantamine 60 dasatinib Sprycel 60 cetuximab Erbitux ® 60 ZOLINZA 60 Iressa gefitinib 60 Camptosar ® 60 teriflunomide 60 OMP #M# 60 Fenretinide 60 proteasome inhibitors 60 Kinase Inhibitor 60 Irinotecan 60 Ixempra 60 iniparib 60 Xelox 60 Afinitor everolimus 60 sipuleucel T 60 Pfizer Sutent 60 Iloperidone 60 Quinamed 60 Omacetaxine 60 luteinizing hormone releasing 60 Voreloxin 60 sunitinib malate 60 Angiotensin Converting Enzyme 60 ReoPro 60 phase IIb clinical 60 entinostat 60 Torisel 60 Adenoma Prevention 60 PDE4 inhibitor 60 Gleevec imatinib 60 Velcade bortezomib 60 Hedgehog Pathway Inhibitor 60 antiarrhythmic 60 Adentri 60 Tarceva TM 60 Anti VEGF 60 Ticagrelor 60 docetaxel Taxotere ® 60 Sutent sunitinib 60 davunetide intranasal AL 60 Votrient 60 Lu AA# 60 PI3K inhibitor 60 Rituxan rituximab 60 selective androgen receptor modulator 60 Pirfenidone 60 PSMA ADC 60 Abbokinase 60 Octreotide 60 BRIM2 60 Factor VIIa 60 orally bioavailable 60 docetaxel Taxotere R 60 LY# [003] 60 Gemcitabine 60 FK# 60 brivaracetam 60 atrasentan 60 Vaprisol 60 Tykerb lapatinib 59 Dacogen decitabine 59 farletuzumab 59 tipifarnib 59 DNA intercalator 59 BiTE 59 Hsp# Inhibitor 59 Fingolimod 59 Rivaroxaban 59 histone deacetylase inhibitor 59 Elagolix 59 compound AEZS 59 Cetuximab Erbitux 59 mTOR inhibitors 59 PKC# 59 Raltegravir 59 bendamustine 59 PrevOnco 59 Receptor Antagonists 59 Cinquil 59 Plicera 59 Nexavar ® 59 Myelodysplastic Syndrome MDS 59 paclitaxel Taxol 59 PEG SN# 59 basiliximab 59 Trexima 59 Cladribine 59 AS# amonafide L malate 59 Fulvestrant 59 OncoVex 59 phase IIb trial 59 BMS # 59 Anidulafungin 59 ProSavin 59 HuMax EGFr 59 Zarnestra 59 baminercept 59 angiotensin II receptor blocker 59 Fesoterodine 59 OSI Tarceva 59 Blinatumomab 59 ocular formulation 59 Naproxcinod 59 endostatin 59 talabostat 59 virus HCV protease inhibitor 59 phase IIa 59 vidofludimus 59 goserelin 59 proteasome inhibitor bortezomib 59 Ropinirole 59 Abiraterone 59 Maraviroc 59 torezolid 59 Axitinib 59 HSP# inhibitor 59 Trastuzumab 59 thrombin receptor 59 blood clot preventer 59 Candesartan 59 ADP receptor antagonist 59 BZL# 59 selective modulator 59 dexpramipexole 59 novel peptide 59 fostamatinib disodium 59 zafirlukast 59 Erlotinib 59 Reverset 59 tremelimumab 59 ORAL Sync 59 Romidepsin 59 Olmesartan 59 Phase IIb clinical trials 59 Proxinium TM 59 prasugrel Effient 59 DU #b 59 Imatinib 59 midstage studies 59 Pivotal Phase III 59 HuLuc# 59 CDP# 59 SCH # 59 alpha 2a 59 KB# [002] 59 gemcitabine Gemzar 59 Valdoxan 59 Arranon 59 concurrent chemoradiation 59 Epratuzumab 59 Alemtuzumab 59 CETP inhibitor 59 Elvitegravir 59 Genentech Herceptin 59 TG# [003] 59 visilizumab 59 bevacizumab Avastin 59 Silodosin 59 kinase inhibitor 59 erlotinib Tarceva ® 59 Lamotrigine 59 ALGRX 59 deforolimus 59 Epivir 59 angiotensin receptor blocker ARB 59 Factor Xa inhibitor 59 EndoTAG TM -1 59 itraconazole 59 chimeric monoclonal antibody 59 CCR2 59 GLP1 59 DXL# 59 selective estrogen receptor 59 RSR# 59 orBec 59 Dapagliflozin 59 Sutent sunitinib malate 59 non nucleoside inhibitor 59 Abatacept 59 RhuDex ® 59 gonadotropin releasing hormone GnRH 59 LHRH agonists 59 factor Xa 59 Tarvacin 59 Telcyta 59 Roche Xeloda 59 Bruton tyrosine kinase Btk 59 INCB# [003] 59 tipranavir 59 Panzem R NCD 59 antifibrotic 59 novel oral anticoagulant 59 Telmisartan 59 Novartis Gleevec 59 anti angiogenic agents 59 vascular disrupting 59 Emend 58 Herceptin trastuzumab 58 cholinesterase inhibitors 58 Tesetaxel 58 figitumumab 58 irbesartan 58 rNAPc2 58 tyrosine kinase inhibitor TKI 58 antisense oligonucleotide 58 Panitumumab 58 targeted antifolate 58 Trabectedin 58 Revlimid lenalidomide 58 Pimavanserin 58 ASTEROID 58 demethylating agent 58 CYC# 58 Muraglitazar 58 abiraterone 58 CCX# 58 2DG 58 anticancer agent 58 ATL# [001] 58 Zomig 58 SUTENT ® 58 Eribulin 58 KRN# 58 Apixaban 58 ponatinib 58 targeted radiotherapeutic 58 HGS ETR2 58 SERMs 58 Rasagiline 58 Sym# 58 brivanib 58 GSK# [001] 58 Apoptone 58 Enzastaurin 58 Recentin 58 5alpha reductase 58 pazopanib 58 flavopiridol 58 etanercept Enbrel 58 selectively inhibits 58 Nuvion 58 IMiD 58 Tacrolimus 58 Humira adalimumab 58 Desmoteplase 58 riociguat 58 INCB# [001] 58 decitabine 58 Liraglutide 58 enzyme inhibitor 58 HIF PHI 58 Carvedilol 58 Starlix 58 Methylnaltrexone 58 GRN# 58 Phase IIB 58 receptor blocker 58 humanised monoclonal antibody 58 PSN# [002] 58 Bicalutamide 58 oral prodrug 58 TLR9 agonist 58 darapladib 58 RhuDex 58 IMC A# 58 investigational humanized monoclonal antibody 58 corticosteroid dexamethasone 58 Sipuleucel T 58 Laquinimod 58 Phase Ib study 58 Darusentan 58 Tasigna nilotinib 58 Bonefos 58 Sprycel dasatinib 58 Linaclotide 58 Telaprevir 58 Alfimeprase 58 Cimzia ® certolizumab pegol 58 AMN# [001] 58 sorafenib tablets 58 Interferon beta 58 Ocrelizumab 58 CYT# potent vascular disrupting 58 adipiplon 58 Gefitinib 58 candesartan cilexetil 58 somatostatin analogue 58 cladribine 58 multikinase inhibitor 58 chemotherapy FOLFOX 58 peptibody 58 Amevive 58 Vidaza azacitidine 58 Cellcept 58 SABCS 58 protein tyrosine phosphatase 1B 58 alkylating agent 58 Vicriviroc 58 receptor inhibitor 58 methylnaltrexone 58 EGS# 58 MEVACOR 58 Infliximab 58 CG# [003] 58 Pazopanib 58 huC# DM4 58 nucleoside analog 58 Panzem NCD 58 Aptivus ® 58 tezampanel 58 Nuedexta 58 ECTRIMS 58 Taxol paclitaxel 58 ZACTIMA 58 antiproliferative effects 58 Tanespimycin 58 Leukine 58 E2F Decoy 58 antidiabetic 58 Reolysin 58 Doxil ® 58 selective antagonist 58 small molecule tyrosine 58 Vilazodone 58 depsipeptide 58 Advexin 58 Bevacizumab 58 Akt inhibitor 58 MGd 58 JAK2 inhibitor 58 potent antiproliferative 58 Hormone Refractory Prostate Cancer 58 TLR8 agonist 58 Sanofi Aventis Taxotere 58 Natalizumab 58 PARP inhibitors 58 Clinical Trial Results 58 Randomized Phase 58 Requip XL 58 IFN beta 58 Vandetanib 58 Degludec 58 BAL# [001] 58 oral salmon calcitonin 58 IFN α 58 bicifadine 57 Febuxostat 57 anidulafungin 57 CA4P 57 Bucindolol 57 TH# [003] 57 pegylated interferons 57 potent suppressor 57 Acapodene 57 CDK inhibitor 57 TLK# 57 Doxorubicin 57 Vernakalant 57 lumiliximab 57 Trastuzumab DM1 57 Milnacipran 57 Genentech Lucentis 57 Janus Kinase 57 ocrelizumab 57 BAL# [002] 57 PCK# 57 Atrasentan 57 Dendreon Provenge 57 fluvastatin 57 5 Fluorouracil 57 ASCO GI 57 blood thinner Xarelto 57 SCCHN 57 heparins 57 BZA CE 57 Adenoscan R 57 Avanafil 57 temsirolimus 57 rHuEPO 57 Emselex 57 Saxagliptin 57 Ridaforolimus 57 cancer neuroendocrine tumor 57 Belatacept 57 immunosuppressant drug 57 Firazyr 57 tolvaptan 57 cathepsin K inhibitor 57 GDIR 57 delafloxacin 57 EOquin TM 57 Bevasiranib 57 Lapatinib 57 Squalamine 57 #th Annual Interscience 57 sodium glucose cotransporter 57 Levoleucovorin 57 Ziprasidone 57 Erbitux 57 Campath ® 57 Victrelis 57 HGS# 57 Cabazitaxel 57 Roflumilast 57 chemotherapeutic regimen 57 compound perifosine 57 PEGylated Fab fragment 57 NXL# 57 IAP inhibitor 57 Nilotinib 57 vivo validation 57 Ceflatonin R 57 eniluracil 57 carvedilol 57 meropenem 57 Sutent 57 Antisense 57 crizotinib 57 trastuzumab Herceptin 57 nitric oxide donating prostaglandin 57 Vfend 57 CRLX# 57 novel histone deacetylase 57 HCV protease inhibitor 57 HQK 57 Gaboxadol 57 bicalutamide 57 gemcitabine Gemzar ® 57 Tezampanel 57 Fibrillex 57 SRT# [003] 57 multicenter Phase II 57 IRX 2 57 Tarceva erlotinib 57 Vorapaxar 57 Personalized Immunotherapy 57 BN# [002] 57 Ipilimumab 57 Tocosol 57 Angiolix 57 selective kinase inhibitor 57 PegIntron 57 dihydrochloride 57 Archexin 57 dacetuzumab 57 Tolvaptan 57 Lubiprostone 57 Taxol ® 57 timolol 57 Orazol 57 Clolar ® 57 AKT inhibitor 57 ruboxistaurin 57 gastrointestinal stromal tumors 57 glatiramer 57 SGS# 57 pioglitazone HCl 57 ASA# 57 GSK# [002] 57 Fablyn 57 investigational protease inhibitor 57 Bevirimat 57 CIMZIA TM 57 GRN#L 57 VAPRISOL 57 immunomodulatory therapy 57 Omapro 57 multiple myeloma MM 57 Anavex #-# 57 Genentech Roche 57 Tykerb 57 lenalidomide Revlimid 57 Telintra 57 AZT zidovudine Retrovir 57 topically administered 57 Tocilizumab 57 muraglitazar 57 long acting muscarinic 57 Cetrorelix 57 Neulasta ® 57 vinorelbine tartrate 57 Meets Primary Endpoint 57 omacetaxine mepesuccinate 57 CCR5 inhibitor 57 Aurora Kinase 57 Campath alemtuzumab 57 PRT# 57 Merck KGaA Erbitux 57 antitumor effects 57 Phase 2a Clinical Trial 57 Kahalalide F 57 antiangiogenic 57 Perifosine 57 Decitabine 57 FTY# 57 imatinib mesylate Gleevec 57 liposomal doxorubicin 57 PD LID 57 Certriad 57 tocilizumab 57 Tofacitinib 57 glycoprotein GP IIb IIIa 57 Teriflunomide 57 Elotuzumab 57 Preclinical studies suggest 57 Amgen Vectibix 57 Atacand 57 Tekamlo 57 cancer immunotherapies 57 rivastigmine Exelon 57 vandetanib 57 aliskiren 57 zalutumumab 57 Advagraf 57 anastrozole Arimidex 57 Gemzar gemcitabine 57 RGB # 57 plasma kallikrein inhibitor 57 peginesatide 57 OXi# 57 Cimzia certolizumab pegol 57 aspirin clopidogrel 57 Enbrel etanercept 57 BRAF inhibitors 57 antiangiogenic agent 57 Golimumab 57 Taxotere docetaxel 57 Aplidin R 57 T#I [002] 57 BEMA TM Fentanyl 57 NVA# 57 AVE# 57 Relovair 57 AZILECT ® 57 RSD# 57 CYT# QbG# 57 imatinib Gleevec 57 renin inhibitors 57 PRIALT 57 Promacta 57 TNF inhibitor 57 radezolid 57 Gleevac 57 Onconova 57 Late Breaker 57 imatinib Gleevec ® 57 Teriparatide 57 Rilutek 57 Kynapid 57 Zemplar 57 Amgen denosumab 56 trial evaluating PRX# 56 MEK inhibitors 56 interferon beta 56 CCR5 antagonist 56 pegylated liposomal doxorubicin 56 Carboplatin 56 metastatic renal cell carcinoma 56 Vivecon 56 administered subcutaneously 56 CorVue ™ 56 Talabostat 56 Troxatyl 56 sitaxsentan 56 Novantrone 56 JAK3 inhibitor 56 Huntexil 56 RAV# 56 Clofarabine 56 Ampakine 56 Tipranavir 56 Bosutinib 56 Gleevec Glivec 56 tubulin inhibitor 56 solanezumab 56 Mycamine 56 GAMMAGARD 56 TRV# [001] 56 NV1FGF 56 Sprycel 56 Radezolid 56 highly selective inhibitor 56 Imprime PGG 56 subcutaneously administered 56 Varespladib 56 sertraline Zoloft 56 fludarabine phosphate 56 efalizumab 56 imatinib mesylate 56 cytokine refractory 56 prostate cancer mCRPC 56 lasofoxifene 56 AstraZeneca Iressa 56 valsartan Diovan 56 Xeloda ® 56 2 methoxyestradiol #ME# 56 GLYX 56 bapineuzumab 56 xanthine oxidase inhibitor 56 Prograf ® 56 Interferon alpha 56 Serdaxin 56 Gattex 56 PI3K/Akt pathway inhibitor 56 aprepitant 56 phosphatidylserine PS targeting 56 Effexor venlafaxine 56 Bayer Onyx 56 CytoFabTM 56 MAGE A3 ASCI 56 Removab 56 Ontak 56 dexamethasone Decadron 56 #ME# 56 TNFα 56 oral rivaroxaban 56 Aptocine 56 acyclovir Lauriad R 56 beta 1a 56 Phase IIa trials 56 TELINTRA 56 Tarvacin TM 56 anti androgen 56 reslizumab 56 AMD# [003] 56 Adenoscan 56 Actilon 56 Gemzar ® 56 Glypromate 56 anti VEGF 56 rhThrombin 56 5 HT2A receptor 56 anti angiogenesis 56 mesylate 56 Azedra 56 fenretinide 56 Vectibix panitumumab 56 Fludarabine 56 Remicade infliximab 56 Pegintron 56 oral chemotherapeutic agent 56 docetaxel chemotherapy 56 Valtropin 56 PEG IFN 56 Dalbavancin 56 pregabalin Lyrica 56 Urocidin 56 alvespimycin 56 Evoltra 56 coxib 56 GAP #B# 56 TMC# [002] 56 Tiazac 56 Nexavar tablets 56 mitogen activated ERK kinase 56 KSP inhibitor 56 FOLOTYN ® 56 cabazitaxel 56 CB2 selective receptor agonist 56 RP# [002] 56 Micardis ® 56 galiximab 56 TREANDA 56 ezetimibe Zetia 56 ibandronate 56 humanized antibody 56 samalizumab 56 Nexavar sorafenib tablets 56 humanized anti 56 azilsartan medoxomil 56 docetaxel Taxotere 56 antiangiogenesis 56 Topotecan 56 odanacatib 56 tolevamer 56 GLP1 agonist 56 cidofovir 56 OncoVEX GM CSF 56 YONDELIS R 56 GVAX 56 Gastrointestinal Cancers Symposium 56 receptor modulators 56 ganetespib 56 icatibant 56 Capecitabine 56 Serdolect ® 56 JAK1 56 Seliciclib 56 Vinorelbine 56 nucleotide analogue 56 QVA# 56 Folotyn 56 exemestane Aromasin 56 humanised antibody 56 HDACi 56 JAK inhibitors 56 Xcellerated T Cells 56 serotonin norepinephrine reuptake inhibitor 56 Mg Usa 56 BARACLUDE ® 56 metastatic colorectal 56 Zalbin 56 endothelin antagonist 56 fingolimod 56 IV Busulfex 56 Dabigatran etexilate 56 Rezonic 56 Vertex telaprevir 56 recurrent GBM 56 Glatiramer acetate 56 compound INCB# 56 Tamsulosin 56 aflibercept 56 Entecavir 56 Combination REOLYSIN R 56 RH1 56 matrix metalloproteases 56 ACV1 56 Roche Pegasys 56 bevacizumab Avastin ® 56 RezularTM 56 huN# DM1 56 DAVANAT 56 Erbitux ImClone 56 Dutasteride 56 Symadex 56 Etanercept 56 aleglitazar 56 Losartan 56 midstage clinical trials 56 XL# [003] 56 agomelatine 56 ongoing Phase 1b 56 investigational transdermal 56 AASLD Meeting 56 Uplyso 56 ALK inhibitors 56 vismodegib 56 investigational monoclonal antibody 56 desvenlafaxine 56 Angiocept 56 trabectedin 56 IMC #B 56 Intelence 56 capecitabine Xeloda 56 SAR# [004] 56 HCV NS5B polymerase 56 Prilosec omeprazole 56 Fx #A 56 EGF receptor 56 cangrelor 56 prochlorperazine 56 bleomycin 56 Phase 1a clinical 56 Platinol 56 Pivotal Phase 56 Oxaliplatin 56 Vertex hepatitis C 56 personalized immunotherapy 56 phase IIb 56 Affinitak 56 alemtuzumab Campath 56 SIR Spheres 56 pioglitazone Actos 56 AEG# 56 preclinically 56 Hydroxyurea 56 Eli Lilly Cymbalta 56 CRx 56 Rebif ® 56 reversible inhibitor 56 CCR9 56 Insegia 56 ATL/TV# 56 modulators SERMs 56 tranilast 56 orally disintegrating 56 rabeprazole 56 ARC# [002] 56 Noxafil 56 Cytochrome P# 56 LymphoStat B 56 trodusquemine 56 intravenously administered 56 Interferon Alfa 56 glatiramer acetate 56 Monoclonal antibody 56 Copegus ribavirin 56 triphendiol 56 Indiplon 56 leflunomide 56 olmesartan 56 mediated inhibition 56 mitoxantrone plus 56 pharmacodynamic profile 56 Crofelemer 56 nefazodone 56 CBLC# 56 BrachySil TM 56 S/GSK# 56 relapsed leukemia 56 Celebrex celecoxib 56 combinability 56 Antegren 56 Vpriv 56 romidepsin 56 HYCAMTIN 56 Diovan HCT 56 Locked Nucleic Acid LNA 56 tigecycline 56 Gabapentin 56 Oral NKTR 55 photodynamic therapy PDT 55 NM# [003] 55 R#/MEM 55 Recombinant Human 55 Phenoptin 55 mRNA antagonists